Marché mondial des méthodes de localisation des lésions mammaires – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse du marché et de la taille des méthodes de localisation des lésions mammaires

Dans le domaine des méthodes de localisation des lésions mammaires, l'imagerie diagnostique constitue une application fondamentale. Elle implique l'utilisation de modalités telles que la mammographie, l'échographie et l'imagerie par résonance magnétique (IRM) pour visualiser et localiser avec précision les lésions ou anomalies suspectes dans le tissu mammaire. La mammographie, la modalité d'imagerie la plus courante, utilise les rayons X pour détecter les premiers signes de cancer du sein. L'échographie offre une imagerie en temps réel et est particulièrement utile pour évaluer les lésions identifiées sur les mammographies ou pour guider les procédures de biopsie. L'IRM fournit des images détaillées et est souvent utilisée chez les patients à haut risque ou pour évaluer plus en détail les résultats non concluants d'autres modalités d'imagerie. Ces techniques d'imagerie diagnostique jouent un rôle crucial dans la détection précoce, le diagnostic précis et la planification du traitement des patientes atteintes d'un cancer du sein, contribuant de manière significative à l'amélioration des résultats et du pronostic.

Français La taille du marché mondial des méthodes de localisation des lésions mammaires était évaluée à 367,82 millions USD en 2023 et devrait atteindre 977,82 millions USD d'ici 2031, avec un TCAC de 13 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

Breast lesion localization methods refer to techniques used to accurately identify and locate abnormal areas or lesions within the breast tissue. These methods are crucial for guiding diagnostic procedures such as biopsies or surgical interventions, ensuring precise targeting and effective treatment of breast abnormalities, including tumors or other suspicious masses.

Breast Lesion Localization Methods Market Dynamics

Drivers                                                                                          

• Growing Technological Advancements

Innovations in imaging modalities, such as digital mammography, ultrasound, and MRI, offer higher resolution and enhanced sensitivity for detecting breast abnormalities. Moreover, advancements in biopsy techniques, such as vacuum-assisted biopsy and stereotactic biopsy, enable more precise targeting and sampling of lesions, improving diagnostic accuracy. The development of advanced localization devices, such as wire-free localization systems and electromagnetic sensors, enhances procedural efficiency and patient comfort during localization procedures. These technological strides improve patient outcomes and drive market growth by meeting the increasing demand for more effective and minimally invasive breast lesion localization solutions.

• Growing Government Initiatives

Many governments worldwide have implemented initiatives aimed at improving breast cancer screening, diagnosis, and treatment outcomes. Government initiatives often include funding for research and development, subsidizing healthcare costs, and establishing national screening programs. In addition, supportive policies such as reimbursement schemes for diagnostic procedures incentivize healthcare providers to invest in state-of-the-art localization technologies, thereby driving market growth. Government initiatives create a conducive and widespread ecosystem for advancement, ultimately contributing to improved patient care and outcomes.

Opportunities

• High Strategic Partnerships

Collaborations between healthcare institutions, research organizations, and industry players facilitate the exchange of knowledge, resources, and expertise, fostering innovation in localization techniques and devices. These partnerships enable the development of novel technologies that enhance the accuracy, efficiency, and patient outcomes of breast lesion localization procedures. Pooling resources and capabilities, partners can accelerate the translation of research findings into practical solutions, driving market growth and competitiveness. Strategic alliances can expand market reach, enabling companies to penetrate new geographical regions and access previously untapped patient populations, further fueling market expansion.

• Growing Awareness among Consumers

As public awareness campaigns and educational initiatives raise consciousness about breast health, more individuals seek regular screenings and diagnostic procedures. This increased demand for early detection drives the adoption of advanced localization methods, such as mammography, ultrasound, and MRI, facilitating the timely identification and characterization of breast lesions. Consequently, healthcare providers are prompted to invest in state-of-the-art localization technologies to meet the rising demand, thereby driving market growth. Growing awareness encourages healthcare policies and reimbursement schemes that further support the accessibility and utilization of these localization methods, fostering market expansion.

For instance, in October 2021, Wefra Life and Pink Ribbon Germany launched the Breast Cancer Affects Us All campaign, aligning with the growing awareness driver in the breast lesion localization methods market. Through this initiative, the organizations aimed to educate the public about breast cancer and emphasize the importance of early detection. Promoting breast care applications, the campaign encouraged individuals to prioritize regular screenings and diagnostic procedures, ultimately contributing to increased demand for advanced localization methods.

Restraints/Challenges

• High Cost Constraints

Procedures associated with breast lesion localization often come with high expenses, including equipment, diagnostic tests, and medical consultations. These costs can pose barriers to accessibility, particularly for individuals in regions with limited healthcare resources or for those who are underinsured. Moreover, reimbursement policies and coverage limitations may further exacerbate financial burdens for patients seeking these services. The disparity in healthcare spending and affordability issues may hinder widespread adoption of breast lesion localization methods, limiting their impact on early detection and treatment outcomes.

• Limited Access to Healthcare Services

In regions with inadequate healthcare infrastructure, such as rural or underserved areas, accessibility to specialized diagnostic facilities and trained healthcare professionals is limited. Disparities in access to healthcare exacerbate existing inequalities in breast cancer outcomes, particularly for marginalized populations. The lack of screening programs and diagnostic facilities further contributes to underdiagnosis and late-stage presentation of breast cancer cases, impacting the demand for localization methods and hindering market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2022, MOLLI Surgical and Sunnybrook Health Sciences Centre launched Molli to hospitals across Canada, revolutionizing tumor localization for precise surgery. Molli's innovative technology enhances the accuracy and efficiency of tumor localization procedures, facilitating more targeted surgical interventions and improving patient outcomes nationwide.
• In April 2022, The FDA granted approval to Merit Medical System's Scout Bx delivery system, a wire-free breast localization solution designed for stereotactic and MRI-guided biopsies in breast cancer surgery. This milestone approval signifies a significant advancement in breast lesion localization methods, offering healthcare providers a safer and more efficient alternative to traditional wire-localization techniques. The Scout Bx system's wire-free design enhances patient comfort and streamlines biopsy procedures, contributing to enhanced diagnostic accuracy and improved patient experiences in breast cancer care.

Breast Lesion Localization Methods Market Scope

The market is segmented on the basis of type, biopsy techniques, end user, and usage. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Type

• Wire Localization
• Radioisotope Localization
• Radioactive Seed Localization
• Radio Occult Lesion Localization
• Magnetic Tracers
• Others

Biopsy Techniques

• Fine Needle Aspiration Biopsy
• Core Needle Biopsy
• Surgical Biopsy
• Incisional Biopsy
• Excisional Biopsy
• Vacuum-Assisted Breast Biopsy
• Others

End User

• Diagnostic Centres
• Hospitals
• Oncology Clinics
• Ambulatory Surgical Centres

Usage

• Tumor Identification
• Sentinel Lymph Node Lumpectomy

Breast Lesion Localization Methods Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, type, biopsy techniques, end user, and usage as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

Asia Pacific is expected to dominate the market, bolstered by established players and improving healthcare infrastructure across various countries. Rising government investments in breast cancer research, coupled with increasing public awareness about early detection, further drive market growth. Additionally, the strategic focus of major companies on emerging Asian markets contributes to the expansion of the sector in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Analyse du marché du paysage concurrentiel et des méthodes de localisation des lésions mammaires

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché

Les principaux acteurs opérant sur le marché comprennent :

• SOMATEX Medical Technologies GmbH (Allemagne)
• BD (États-Unis)
• Systèmes médicaux Merit (États-Unis)
• Endomagnetics Ltd (Royaume-Uni)
• Cuisinier (États-Unis)
• Intramedical Imaging, LLC (États-Unis)
• Ranfac Corp. (États-Unis)
• Medtronic (États-Unis)
• Stryker (États-Unis)
• Wright Medical Group NV (Pays-Bas)
• Zimmer Biomet (États-Unis)
• Smith+Nephew (Royaume-Uni)
• Boston Scientific Corporation (États-Unis)
• Organogenesis Inc. (États-Unis)
• Arthrex, Inc. (États-Unis)
• Orthofix Medical Inc. (États-Unis)
• Kubtec X-Ray (États-Unis)
• Miltenyi Biotec GMBH (Allemagne)
• Naviscan (États-Unis)
• PerkinElmer Inc. (États-Unis)
• Thermo Fisher Scientific, Inc. (États-Unis)

SKU-13038